A registration statement has been filed by Monrovia, Calif.-based Staar Surgical with the SEC for an offering of securities, including common stock, debt securities, preferred stock and warrants in hopes of raising up to $200 million. The company, which makes the implantable Evo+ Visian ICL intraocular lens for correcting vision, has no plans to launch the offering at this time.
Staar Surgical seeks to raise $200M in securities offering
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.